1-week vs. 2-week bismuth subsalicylate-based triple therapy for H-pylori:: Results of a US randomized trial.

被引：2
|
作者：
Yang, R
Hamamoto, R
Laine, L
机构：
[1] USC, Sch Med, Los Angeles, CA USA
[2] VA Outpatient Clin, Los Angeles, CA USA
来源：
GASTROENTEROLOGY | 1998年 / 114卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(98)81378-4
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
G1388
引用
收藏
页码：A340 / A340
页数：1
相关论文
共 50 条
  • [1] Randomized comparison of 1-week and 2-week bismuth subsalicylate-based triple therapy for the treatment of H-pylori.
    Yang, R
    Hamamoto, R
    Laine, L
    [J]. GASTROENTEROLOGY, 1996, 110 (04) : A302 - A302
  • [2] 2-week is better than 1-week triple therapy for H. pylori eradication
    [J]. Nature Clinical Practice Gastroenterology & Hepatology, 2007, 4 (4): : 180 - 180
  • [3] Comparison of 1-week and 2-week triple therapy with omeprazole, amoxicillin, and clarithromycin in peptic ulcer patients with Helicobacter pylori infection:: results of a randomized controlled trial
    Kiyota, K
    Habu, Y
    Sugano, Y
    Inokuchi, H
    Mizuno, S
    Kimoto, K
    Kawai, K
    [J]. JOURNAL OF GASTROENTEROLOGY, 1999, 34 : 76 - 79
  • [4] Randomized Trial of 1-Week vs. 2-Week Intervals for Endoscopic Ligation in the Treatment of Patients With Esophageal Variceal Bleeding
    Sheibani, Sarah
    Khemichian, Saro
    Hou, Linda A.
    Kim, John J.
    Yan, Arthur
    Buxbaum, James L.
    Dara, Lily
    Laine, Loren
    [J]. GASTROINTESTINAL ENDOSCOPY, 2015, 81 (05) : AB121 - AB122
  • [5] Second-line Helicobacter pylori Eradication: A Randomized Comparison of 1-week or 2-week Bismuth-containing Quadruple Therapy
    Chung, Jun-Won
    Lee, Jeong Hoon
    Jung, Hwoon-Yong
    Yun, Sung-Cheol
    Oh, Tae-Hoon
    Choi, Kee Don
    Song, Ho June
    Lee, Gin Hyug
    Kim, Jin-Ho
    [J]. HELICOBACTER, 2011, 16 (04) : 289 - 294
  • [6] One week triple vs. quadruple therapy for curing Helicobacter pylori infection.: A randomized trial.
    Calvet, X
    Ducons, J
    Guardiola, J
    Tito, L
    Andreu, V
    Bori, F
    Guirao, R
    [J]. GASTROENTEROLOGY, 2002, 122 (04) : A65 - A65
  • [7] Prospective randomized comparison of 1-week RBC triple therapy versus 1-week PPI triple therapy for H-pylori-related duodenal ulcers.
    Sung, JY
    Leung, WK
    Ling, TKW
    Yung, MY
    Chan, KL
    Lee, YT
    Chung, SCS
    Cheng, AFB
    [J]. GASTROENTEROLOGY, 1998, 114 (04) : A296 - A297
  • [8] 2-week triple therapy for Helicobacter pylori infection is better than 1-week in clinical practice:: A large prospective single-center randomized study
    Paoluzi, Paolo
    Iacopini, Federico
    Crispino, Pietro
    Nardi, Francesco
    Bella, Antonino
    Rivera, Margherita
    Rossi, Pina
    Gurnari, Maurizio
    Caracciolo, Francesco
    Zippi, Maddalena
    Pica, Roberta
    [J]. HELICOBACTER, 2006, 11 (06) : 562 - 568
  • [9] A one-week triple therapy vs a two-week dual therapy for eradication and healing of H-pylori (Hp) positive duodenal ulcers (DU): Results from a randomized, double blind clinical trial.
    Saggioro, A
    [J]. GASTROENTEROLOGY, 1997, 112 (04) : A156 - A156
  • [10] Optimal compliance eliminates differences in eradication rates between 2-week dual and 1-week triple therapy for Helicobacter pylori gastritis
    Erdag, S
    Bojko, JB
    Burlage, M
    Schwarzhoff, R
    Braden, B
    Lembeke, B
    Folsch, UR
    Schmidt, WE
    [J]. GASTROENTEROLOGY, 1996, 110 (04) : A103 - A103
12345